{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T04:38:26Z","timestamp":1722832706548},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T00:00:00Z","timestamp":1556582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.aohep.2019.03.008","type":"journal-article","created":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T05:42:35Z","timestamp":1557380555000},"page":"777-779","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Anaphylaxis preceded by erythema multiforme with sorafenib: First case report"],"prefix":"10.1016","volume":"18","author":[{"given":"Augusto","family":"Mantovani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rio Reis","family":"\u00c1lvares-Da-Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.aohep.2019.03.008_bib0080","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL Clinical Practice Guidelines: management of hepatocellular carcinoma","volume":"69","author":"European Association for the Study of the Liver","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2019.03.008_bib0085","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.aohep.2019.03.008_bib0090","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.aohep.2019.03.008_bib0095","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1159\/000490378","article-title":"Sorafenib for advanced hepatocellular carcinoma: a real-life experience","volume":"36","author":"Longo","year":"2018","journal-title":"Dig Dis"},{"key":"10.1016\/j.aohep.2019.03.008_bib0100","doi-asserted-by":"crossref","first-page":"263","DOI":"10.5604\/16652681.1231587","article-title":"The impact of early dermatologic events in the survival of patients with hepatocellular carcinoma treated with sorafenib","volume":"16","author":"Branco","year":"2017","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.aohep.2019.03.008_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17474124.2017.1373018","article-title":"Hand\u2013foot skin reaction is a beneficial indicator of sorafenib therapy for patients with hepatocellular carcinoma: a systemic review and meta-analysis","volume":"12","author":"Wang","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2019.03.008_bib0110","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jaad.2006.10.981","article-title":"Sorafenib-induced erythema multiforme","volume":"56","author":"MacGregor","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.aohep.2019.03.008_bib0115","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1159\/000351918","article-title":"Stevens\u2013Johnson syndrome induced by sorafenib for metastatic renal cell carcinoma","volume":"91","author":"Ikeda","year":"2013","journal-title":"Urol Int"},{"key":"10.1016\/j.aohep.2019.03.008_bib0120","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/jjco\/hys103","article-title":"Erythema multiforme induced by sorafenib for metastatic renal cell carcinoma","volume":"42","author":"Ikeda","year":"2012","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.aohep.2019.03.008_bib0125","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1080\/15569520902915469","article-title":"Sorafenib-induced erythema multiforme in metastatic renal cell carcinoma","volume":"28","author":"Bilac","year":"2009","journal-title":"Cutaneous Ocular Toxicol"},{"key":"10.1016\/j.aohep.2019.03.008_bib0130","first-page":"1015","article-title":"Sorafenib-induced erythema multiforme: three cases","volume":"21","author":"Namba","year":"2001","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.aohep.2019.03.008_bib0135","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/annonc\/mdq299","article-title":"Sorafenib-induced erythema multiforme for metastatic renal cell carcinoma","volume":"21","author":"Kodaira","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.aohep.2019.03.008_bib0140","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1001\/jamadermatol.2015.2930","article-title":"Sorafenib-induced eruption mimicking erythema multiforme","volume":"152","author":"Pichard","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.aohep.2019.03.008_bib0145","series-title":"Anaphylaxis. StatPearls [Internet]","author":"McLendon","year":"2018"},{"key":"10.1016\/j.aohep.2019.03.008_bib0150","first-page":"7","article-title":"International consensus on (ICON) anaphylaxis","volume":"30","author":"Simons","year":"2014","journal-title":"World Allergy Organ J"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268119300997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268119300997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T15:31:18Z","timestamp":1567611078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268119300997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1665268119300997"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2019.03.008","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anaphylaxis preceded by erythema multiforme with sorafenib: First case report","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2019.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C.","name":"copyright","label":"Copyright"}]}}